ZOGENIX INC's ticker is ZGNX and the CUSIP is 98978L204. A total of 152 filers reported holding ZOGENIX INC in Q3 2021. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $194,000 | -52.7% | 12,785 | -46.2% | 0.01% | -50.0% |
| Q2 2021 | $410,000 | -37.7% | 23,754 | -29.5% | 0.02% | -42.1% |
| Q1 2021 | $658,000 | +24.4% | 33,713 | +27.5% | 0.04% | 0.0% |
| Q4 2020 | $529,000 | +65.8% | 26,443 | +48.6% | 0.04% | +280.0% |
| Q3 2020 | $319,000 | -57.5% | 17,795 | -35.9% | 0.01% | -47.4% |
| Q2 2020 | $750,000 | -46.6% | 27,779 | -51.1% | 0.02% | -48.6% |
| Q1 2020 | $1,405,000 | -67.7% | 56,832 | -31.9% | 0.04% | -39.3% |
| Q4 2019 | $4,353,000 | +348.8% | 83,501 | +244.5% | 0.06% | +454.5% |
| Q3 2019 | $970,000 | +171.7% | 24,237 | +273.5% | 0.01% | +57.1% |
| Q1 2019 | $357,000 | -6.1% | 6,489 | -37.8% | 0.01% | -12.5% |
| Q4 2018 | $380,000 | -15.2% | 10,427 | +15.5% | 0.01% | -11.1% |
| Q3 2018 | $448,000 | +6.4% | 9,025 | -5.3% | 0.01% | -18.2% |
| Q2 2018 | $421,000 | +12.0% | 9,526 | +1.5% | 0.01% | 0.0% |
| Q1 2018 | $376,000 | – | 9,387 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 2,502,259 | $40,662,000 | 13.40% |
| HealthInvest Partners AB | 195,000 | $3,169,000 | 4.47% |
| CADIAN CAPITAL MANAGEMENT, LP | 4,090,846 | $66,476,000 | 3.66% |
| Prosight Management, LP | 362,909 | $5,897,000 | 3.53% |
| SCOPIA CAPITAL MANAGEMENT LP | 1,284,705 | $20,876,000 | 1.97% |
| Kynam Capital Management, LP | 205,800 | $3,344,000 | 1.79% |
| Western Standard LLC | 160,656 | $2,611,000 | 1.54% |
| Ikarian Capital, LLC | 590,400 | $9,594,000 | 1.43% |
| RA Capital Management | 3,333,700 | $54,173,000 | 0.96% |
| Knott David M Jr | 134,688 | $2,189,000 | 0.74% |